Biochemistry analyzers are machines designed for analyzing blood, cerebral spinal fluid, urine, and other biological samples. These machines are equipped with electrochemical and optical technologies for measuring characteristics of the sample. Most of these analyzers use optical technologies for performing the measurements such as colorimetric, spectrometric, absorption, and fluoroscopic detection methods. These machines can also measure chemicals such as antigens, proteins, and molecules in body fluids. These analyzers offer several benefits such as fast measurement ability, accuracy, and high sensitivity when detecting even minuscule amount of chemicals.
On the basis of technology, the biochemistry analyzers market has been segmented into semi-automatic and automatic. In case of automatic analyzers, samples can be processed singly, or in batches, or continuously. These analyzers require minimal human assistance while measuring chemical content in sample. The automatic analyzers can be classified into two types of multi-parameter analytical systems. First type is used for high throughput clinical analysis and second type is configured for bioreactor monitoring. Automatic analyzers offer benefits such as lack of errors in measuring, quick analysis, and convenience in using. Owing to these advantages, demand for automatic analyzers is expected to increase in coming years.
On the basis of modality, the biochemistry analyzers market has been divided into bench top, and floor standing. Bench top analyzers are comparatively small in size and can be used with significant level of flexibility. In addition, in small laboratory settings, benchtop analyzes are preferred over space consuming floor standing analyzers. Considering the convenience benefits offered, growth rate of demand for bench top analyzers is expected to surpass the demand for floor standing analyzers during the forecast period.
On the basis of capacity, the biochemistry analyzers market has been divided into high (600+ samples/hour), medium (300-600 samples/hour), and low (less than samples/hour). In high end pharmaceutical companies, analyzers with high capacity are mostly used owing to benefits offered by the system such as handling large number of sample at a specific time, quick turnaround time, and low lifecycle cost.
On the basis of end user, the biochemistry analyzers market has been segmented into hospitals, diagnostics centers, pharmaceutical and biotechnology companies, academic research institutes, and contract research organizations. Hospitals and diagnostics centers covers all type of hospitals, clinics, family planning service providers, epidemic prevention stations, and testing labs. These analyzers are widely used in both hospitals and diagnostics centers.
The major growth driver identified in the biochemistry analyzers market is growing demand for these analyzers in hospitals, and pharmaceutical companies. With the rising numbers of patients with kidney diseases, liver failures, and diabetes, demand for analysis of blood biochemistry parameters of these patients is also increasing. As a result, demand for these analyzers has also been growing.
Growth of the biochemistry analyzers market is hindered by factors such as its complex system integration is complex and high upfront cost. High upfront cost has dented its attractiveness among price sensitive customers in countries from Asia-Pacific.
Product innovation related analyzers that can detect DNA molecules in the samples is identified as future growth opportunity for the biochemistry analyzers market.
Insights by geography
On the basis of both value and volume, North America dominated the market in 2017. High penetration of these analyzers in countries such as U.S. and Canada are attributed to its strong base of pharmaceutical and healthcare sector. From supply side, many of the producers of biochemistry analyzers are located in this region and they have strong distribution channel penetration across hospitals, diagnostics centers, pharmaceutical and biotechnology companies, and academic research institutes.
Some of the major players operating in the global biochemistry analyzers market are Abbott, Siemens AG, Thermo Fisher Scientific, HORIBA, Ltd., F. Hoffmann-La Roche Ltd, Beckman Coulter Inc., Hologic, Inc., Danaher Corporation, Meril Life Sciences Pvt. Ltd., and Randox Laboratories Ltd.